Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,080,230
+$706,060 QoQ
Shares Held
339,907
+70.9% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#25
of 172 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. VNDA ranks #63 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in VNDA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,080,230 | 339,907 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,374,170 | 198,867 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,178,916 | 473,800 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $688,620 | 138,000 | Shares | Defined | 2025-11-13 | |
| 2024-12-31 | $490,883 | 102,481 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $362,128 | 77,213 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $737,115 | 130,463 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $271,768 | 64,400 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $316,879 | 73,352 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $621,331 | 94,284 | Shares | Sole | 2024-10-21 | |
| 2023-03-31 | $333,389 | 49,100 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $375,138 | 50,763 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $503,880 | 51,000 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $589,690 | 54,100 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $790,571 | 50,387 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 ALXN | — | 2,204 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $380,636 | 25,342 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 ALXN | — | 1,968 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||